Evaluation of peripheral serotonin content and α₂-adrenergic receptor function as potential markers for life-long recurrent depressive disorder by using methodological improvements

References

• Baudouin-Legros, M., Le Quan-Bui, K. H., Guicheney, P., Kamal, L. A., & Meyer, P. (1985). Platelet serotonin in essential hypertension and in mental depression. Journal of Cardiovascular Pharmacology, 7, 12–14.
   PubMed Web of Science ®Google Scholar
• Bhagwagar, Whale, R., & Cowen, P. J. (2002). State and trait abnormalities in serotonin function in major depression. The British Journal of Psychiatry: The Journal of Mental Science, 180, 24–28. doi: 10.1192/bjp.180.1.24
   PubMed Web of Science ®Google Scholar
• Born, G. V. (1962). Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194, 927–929. doi: 10.1038/194927b0
   PubMed Web of Science ®Google Scholar
• Bunney, W. E., Jr., & Davis, J. M. (1965). Norepinephrine in depressive reactions. A review. Archives of General Psychiatry, 13, 483–494. doi: 10.1001/archpsyc.1965.01730060001001
   PubMed Web of Science ®Google Scholar
• Cattaneo, M., Cerletti, C., Harrison, P., Hayward, C. P., Kenny, D., Nugent, D., … Michelson, A. D. (2013). Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. Journal of Thrombosis and Haemostasis, 11, 1183–1189. doi: 10.1111/jth.12231
   Web of Science ®Google Scholar
• Ellis, P. M., & Salmond, C. (1994). Is platelet imipramine binding reduced in depression? A meta-analysis. Biological Psychiatry, 36, 292–299. doi: 10.1016/0006-3223(94)90626-2
   PubMed Web of Science ®Google Scholar
• García-Sevilla, J. A., Guimón, J., García-Vallejo, P., & Fuster, M. J. (1986). Biochemical and functional evidence of supersensitive platelet alpha 2-adrenoceptors in major affective disorder. Effect of long-term lithium carbonate treatment. Archives of General Psychiatry, 43, 51–57. doi: 10.1001/archpsyc.1986.01800010053007
   PubMedGoogle Scholar
• García-Sevilla, J. A., Udina, C., Fuster, M. J., Alvarez, E., & Casas, M. (1987). Enhanced binding of [3H] (-) adrenaline to platelets of depressed patients with melancholia: Effect of long-term clomipramine treatment. Acta Psychiatrica Scandinavica, 75, 150–157. doi: 10.1111/j.1600-0447.1987.tb02767.x
   PubMed Web of Science ®Google Scholar
• García-Sevilla, J. A., Zis, A. P., Hollingsworth, P. J., Greden, J. F., & Smith, C. B. (1981). Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Archives of General Psychiatry, 38, 1327–1333. doi: 10.1001/archpsyc.1981.01780370029003
   PubMedGoogle Scholar
• García-Sevilla, J. A., Zis, A. P., Zelnik, T. C., & Smith, C. B. (1981). Tricyclic antidepressant drug treatment decreases α2- adrenoceptors on human platelet membranes. European Journal of Pharmacology, 69, 121–123. doi: 10.1016/0014-2999(81)90612-9
   PubMed Web of Science ®Google Scholar
• Gonshor, A. (2002). Technique for producing platelet-rich plasma and platelet concentrate: Background and process. The International Journal of Periodontics & Restorative Dentistry, 22, 547–557. doi: 10.11607/prd.00.0495
   PubMed Web of Science ®Google Scholar
• Grunhaus, L. J., Cameron, O., Pande, A. C., Haskett, R. F., Hollingsworth, P. J., & Smith, C. B. (1990). Comorbidity of panic disorder and major depressive disorder: Effects on platelet alpha 2 adrenergic receptors. Acta Psychiatrica Scandinavica, 81, 216–219. doi: 10.1111/j.1600-0447.1990.tb06483.x
   PubMed Web of Science ®Google Scholar
• Harrison, P., Mackie, I., Mumford, A., Briggs, C., Liesner, R., Winter, M., & Machin, S. British Committee for Standards in Haematology. (2011). Guidelines for the laboratory investigation of heritable disorders of platelet function. British Journal of Haematology, 155, 30–44. doi: 10.1111/j.1365-2141.2011.08793.x
   PubMed Web of Science ®Google Scholar
• Karege, F., Bovier, P., Hilleret, H., & Gaillard, J. M. (1993). Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients. Lancet (London, England), 341, 1029. doi: 10.1016/0140-6736(93)91121-2
   PubMed Web of Science ®Google Scholar
• Karege, F., Bovier, P., Widmer, J., Gaillard, J. M., & Tissot, R. (1992). Platelet membrane alpha 2-adrenergic receptors in depression. Psychiatry Research, 43, 243–252. doi: 10.1016/0165-1781(92)90057-A
   PubMed Web of Science ®Google Scholar
• Le Quan-Bui, K. H., Plaisant, O., Leboyer, M., Gay, C., Kamal, L., Devynck, M. A., & Meyer, P. (1984). Reduced platelet serotonin in depression. Psychiatry Research, 13, 129–139. doi: 10.1016/0165-1781(84)90056-8
   PubMed Web of Science ®Google Scholar
• Lenze, E. J., & Wetherell, J. L. (2011). A lifespan view of anxiety disorders. Dialogues in Clinical Neuroscience, 13, 381–399.
   PubMedGoogle Scholar
• Leonard, B. E. (1990). Changes in platelet serotonergic and adrenergic function in patients with depression, panic attack, and mania. In: W. E. Bunney, H. Hippius, G. Laakmann, M. Schmausz, Neuropsychopharmacology: Proceedings of the XVIth C.I.N.P. Congress, Munich, August 15–19 (pp 163–171). Berlin: Springer-Verlag.
   Google Scholar
• Maes, M., Van Gastel, A., Delmeire, L., & Meltzer, H. Y. (1999). Decreased platelet alpha-2 adrenoceptor density in major depression: Effects of tricyclic antidepressants and fluoxetine. Biological Psychiatry, 45, 278–284. doi: 10.1016/S0006-3223(98)00002-X
   PubMed Web of Science ®Google Scholar
• Mann, J. J., McBride, P. A., Anderson, G. M., & Mieczkowski, T. A. (1992). Platelet and whole blood serotonin content in depressed inpatients: Correlations with acute and life-time psychopathology. Biological Psychiatry, 32, 243–257. doi: 10.1016/0006-3223(92)90106-A
   PubMed Web of Science ®Google Scholar
• Markovitz, J. H., Shuster, J. L., Chitwood, W. S., May, R. S., & Tolbert, L. C. (2000). Platelet activation in depression and effects of sertraline treatment: An open-label study. The American Journal of Psychiatry, 157, 1006–1008. doi: 10.1176/appi.ajp.157.6.1006
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej, E., Pittendreigh, C., & Solomons, K. (2004). The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thrombosis and Haemostasis, 91, 119–128. doi: 10.1160/TH03-05-0330
   PubMed Web of Science ®Google Scholar
• Miller, J. M., Brennan, K. G., Ogden, T. R., Oquendo, M. A., Sullivan, G. M., Mann, J. J., & Parsey, R. V. (2009). Elevated serotonin 1A binding in remitted major depressive disorder: Evidence for a trait biological abnormality. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 34, 2275–2284. doi: 10.1038/npp.2009.54
   PubMed Web of Science ®Google Scholar
• Mitani, H., Shirayama, Y., Yamada, T., & Kawahara, R. (2006). Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 531–534. doi: 10.1016/j.pnpbp.2005.11.021
   PubMed Web of Science ®Google Scholar
• Morgadinho, M. T., Fontes Ribeiro, C. A., & Macedo, T. R. (2004). Influence of the sample preparation method on the serotonin determination in plasma and platelets. Biomedical Chromatography: BMC, 18, 739–744. doi: 10.1002/bmc.387
   PubMed Web of Science ®Google Scholar
• Mück-Seler, D., Jakovljević, M., & Deanović, Z. (1991). Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients. Journal of Affective Disorders, 23, 157–164. doi: 10.1016/0165-0327(91)90028-Q
   PubMed Web of Science ®Google Scholar
• Mück-Seler, D., Jakovljević, M., & Pivac, N. (1996). Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression. Journal of Affective Disorders, 39, 73–80. doi: 10.1016/0165-0327(96)00024-9
   PubMed Web of Science ®Google Scholar
• Mück-Seler, D., Pivac, N., Mustapic, M., Crncevic, Z., Jakovljevic, M., & Sagud, M. (2004). Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Research, 127, 217–226. doi: 10.1016/j.psychres.2004.04.001
   PubMed Web of Science ®Google Scholar
• Mück-Seler, D., Pivac, N., Sagud, M., Jakovljević, M., & Mihaljević-Peles, A. (2002). The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26, 1235–1243. doi: 10.1016/S0278-5846(02)00259-2
   PubMed Web of Science ®Google Scholar
• Nakatani, Y., Sato-Suzuki, I., Tsujino, N., Nakasato, A., Seki, Y., Fumoto, M., & Arita, H. (2008). Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. The European Journal of Neuroscience, 27, 2466–2472. doi: 10.1111/j.1460-9568.2008.06201.x
   PubMed Web of Science ®Google Scholar
• Paul-Savoie, E., Potvin, S., Daigle, K., Normand, E., Corbin, J. F., Gagnon, R., & Marchand, S. (2011). A deficit in peripheral serotonin levels in major depressive disorder but not in chronic widespread pain. The Clinical Journal of Pain, 27, 529–534. doi: 10.1097/AJP.0b013e31820dfede
   PubMed Web of Science ®Google Scholar
• Pérez, V., Bel, N., Celada, P., Ortiz, J., Alvarez, E., & Artigas, F. (1998). Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments. Journal of Clinical Psychopharmacology, 18, 222–230. doi: 10.1097/00004714-199806000-00007
   PubMed Web of Science ®Google Scholar
• Pivac, N., Jakovljević, M., Mück-Seler, D., & Brzović, Z. (1997). Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients. Psychiatry Research, 73, 123–132. doi: 10.1016/S0165-1781(97)00120-0
   PubMed Web of Science ®Google Scholar
• Pivac, N., Mück-Seler, D., Sagud, M., Jakovljević, M., Mustapić, M., & Mihaljević-Peles, A. (2003). Long-term sertraline treatment and peripheral biochemical markers in female depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 759–765. doi: 10.1016/S0278-5846(03)00105-2
   PubMed Web of Science ®Google Scholar
• Siever, L. J., Kafka, M. S., Targum, S., & Lake, C. R. (1984). Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Research, 11, 287–302. doi: 10.1016/0165-1781(84)90003-9
   PubMed Web of Science ®Google Scholar
• Sneddon, J. M. (1973). Blood platelets as a model for monoamine-containing neurones. Progress in Neurobiology, 1, 151–198. doi: 10.1016/0301-0082(73)90019-1
   PubMedGoogle Scholar
• Takahashi, S. (1976). Reduction of blood platelet serotonin levels in manic and depressed patients. Folia Psychiatrica Et Neurologica Japonica, 30, 475–486. doi: 10.1111/j.1440-1819.1976.tb02670.x
   PubMedGoogle Scholar
• Wakayama, K., Ohtsuki, S., Takanaga, H., Hosoya, K., & Terasaki, T. (2002). Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells. Neuroscience Research, 44, 173–180. doi: 10.1016/S0168-0102(02)00120-7
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (1994). International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: WHO.
   Google Scholar
• Yang, X., Ma, X., Li, M., Liu, Y., Zhang, J., Huang, B., … Ma, X. (2015). Anatomical and functional brain abnormalities in unmedicated major depressive disorder. Neuropsychiatric Disease and Treatment, 11, 2415–2423. doi: 10.2147/NDT.S93055
   PubMed Web of Science ®Google Scholar
• Zhou, L., & Schmaier, A. H. (2005). Platelet aggregation testing in platelet-rich plasma: Description of procedures with the aim to develop standards in the field. American Journal of Clinical Pathology, 123, 172–183. doi: 10.1309/Y9EC63RW3XG1V313
   PubMed Web of Science ®Google Scholar